From the Sector

The antimicrobial protection of Sanitized® T 99-19 against the SARS-CoV-2 virus has been confirmed by independent labs in France (basis: ISO 18184:2019).

Textile and polymer products with Sanitized® antimicrobial treatment have been used in hygiene-sensitive areas for many years. For textiles, Sanitized® T 99-19 is a patented technology based on a silane-ammonia compound, a globally proven product. Its hygiene function is used in workwear and protective clothing for nursing staff, bed linen or mattresses in hotels, nursing care facilities and hospitals. Polyester goods for precisely these areas of application can now not only be antimicrobial, but also reliably protective against SARS CoV-2.

The antiviral efficacy (99.84 %) of the Sanitized® T 99-19 product has been officially confirmed by tests conducted by external labs.

Tests on end products, which were additionally carried out by textile manufacturers, also prove the effectiveness of Sanitized® T 99-19 against SARS CoV-2. License partners praise this confidence-building benefit of the end products. SANITIZED license partners receive concrete support in terms of marketing and legal aspects (health claims).

Avoid legal pitfalls when claiming antiviral protection
Advice and support for customers in achieving optimal hygiene protection for their products are an integral part of SANITIZED services. A claim guide has therefore been developed especially for products that protect against COVID-19.
https://www.sanitized.com/de/protection-against-covid-19-which-antiviral-advertising-claimsare-legal-sanitized-explains/

The Swiss Technology Award announced the 2020 prizes, and among all the notable finalist innovations of the year, HeiQ was bestowed the highest honor as First Prize Winner for its breakthrough antiviral textile technology HeiQ Viroblock.

Developed in record time and launched after the Swiss authorities announced the lockdown in March 2020, HeiQ Viroblock has had a major impact on the global textile industry and is being unprecedently adopted by mills around the world.

The technology that makes HeiQ Viroblock a unique innovation
What exemplifies HeiQ Viroblock is its ability to turn any fabric antiviral. It’s among the first textile technologies in the world to be proven effective against SARS-CoV-2 (COVID-19). HeiQ Viroblock consists of a combination of HeiQ’s patent-pending vesicle and silver technologies. The two mechanisms of attack result in an over 99.9% destruction of viruses in 5 minutes that is unrivaled in the industry. HeiQ Viroblock is a unique patent-pending formulation of 72% bio-based ingredients, made with 100% cosmetic-grade materials from the International Nomenclature of Cosmetic Ingredients list. HeiQ Viroblock is also a shining example of Swiss cooperation between academics and the industry. The silver technology was developed at ETHZ (Eidgenössische Technische Hochschule Zürich), the vesicle technology at EPFL (École polytechnique fédérale de Lausanne), and the production was scaled up at FHNW (Fachhochschule Nordwestschweiz).

HeiQ Viroblock has demonstrated unparalleled speed from laboratory to consumer
HeiQ launched the new antiviral textile technology HeiQ Viroblock on March 16, 2020 – two hours after Switzerland declared a state of emergency. This was made possible with the indispensable support of Swiss research Partner FHNW and the EPFL which helped accelerate product validation. The fast scale-up of production was enabled by the FHNW School of Life Sciences with their new Process Technology Center (PTC) by special permit. With its agile operations and global footprint, HeiQ also brought HeiQ Viroblock face masks and other PPE (personal protection equipment) to different corners of the world where are needed. Now, Swiss consumers can also acquire HeiQ Viroblock enhanced face masks online.

Reacting to the news of HeiQ Viroblock winning this year’s Swiss Tech Award, Co-founder and CEO Carlo Centonze says: “I am both amazed and honored that HeiQ has won this award a second time in just ten years, and from among some incredible tech innovation finalists. It confirms our resolve to push the boundaries and push innovations to help the world with its most pressing and imminent problems. This award is recognition for our company and team that have spared no efforts to develop and launch HeiQ Viroblock at such speed and make a valuable contribution to the global pandemic efforts. We remain true to our mission: enhancing the everyday lives of people with smart and efficient textile effects.”

Protective masks for Europe
With FleeceforEurope and Lindenpartner, Düsseldorf-based Kloepfel Group purchasing consultancy and Berlin-based industrial consultancy Bechinger & Heymann Holding plan to manufacture and distribute up to 50 million protection class FFP1 through FFP3 respiratory masks a month exclusively for the European market from the beginning of fall. And the primary focus will be on quality.
With protective masks – including those used in operating rooms – this quality is provided above all by  virus-absorbing nonwovens. And these will be manufactured by ‘FleeceforEurope’ using an Oerlikon Nonwoven meltblown system.
But masks effectively protecting against infections can only be guaranteed with the right quality. A crucial factor in this is the inside of the mask. Because the nonwoven used in protection class FFP1 through FFP3 respiratory masks plays a decisive role.
Here, the meltblown technology from Oerlikon Nonwoven will be deployed. In a special, patented process, the fibers laid into a nonwoven fabric during manufacture are subsequently electrostatically-charged, before the material is further processed downstream.

European market for protective masks with a promising future
Those responsible at Oerlikon Nonwoven and FleeceforEurope, which will primarily focus on producing high-end nonwovens, and Lindenpartner, which will manufacture and distribute the protective masks, are certain of one thing: the market for protective masks has a very promising long-term future in Europe.
What has been commonplace in Asia for many years now will also become normal in Europe. People will be increasingly wearing face masks when venturing out, in order to better protect themselves against health risks such as the current pandemic and also against increasing environmental pollution in the form of  fine particles and exhaust fumes in the future. A

Medical face masks from a vending machine
Mask producer Lindenpartner has already secured supplies of nonwovens and will be producing face masks for the European healthcare sector over the coming weeks. To fight the coronavirus pandemic, Lindenpartner is planning to install 100 self-service face mask vending machines in Germany over the next four weeks, positioning them in publicly-accessible places such as shopping centers and airports, for example.

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99 %.

Swiss company SANITIZED AG celebrates validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019).
Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2.

Patented technology featuring an ammonium silicate compound is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology. These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses.
The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Before a final product’s antiviral properties can be publicly promoted, viral tests must be performed in specialized laboratories. Compliance with local legal regulations is essential here. SANITIZED AG explicitly points out that this is standard procedure and has composed a preliminary Guide for Treating PPE

SANITIZED AG has been supporting the work of hygienists in hospitals, doctor’s offices, nursing and care facilities for many years with its antimicrobial - and now also antiviral - additives used to enhance the
functionality of textiles and polymers. The reduction of bacteria and viruses is a feasible way to help stem the spread of infections including MRSA.